STARPHARMA (SLP7013-017)

By June 19, 2019 Closed

“A phase 3, double-blind, multicentre, randomised, placebo-controlled study to determine the efficacy and safety of SPL7013 Gel (VivaGel®) to prevent the recurrence of bacterial vaginosis”

Join the discussion 20,651 Comments